-
Published26/09/2015
-
Deadline22/10/2015
-
Today12/08/2026
Utilities
- indicates text translated automatically in your browsing language
Germany-Tübingen: Various medicinal products
Preparation of a soluble recombinant protein of approximately 31 kDa molecular weight (isoelectric point ((pl): 9,45) expressed in E. coli cells, as a drug substrate (target quantity: at least 10 g cGMP material) and bottling as a drug product (semi-solid formulation) for subsequent nasal use as a test medicinal product in humans.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.